Discontinuation report OPTIMARK

Last updated on 2018-03-28 History
Report ID 8842
Drug Identification Number 02242986
Brand name OPTIMARK
Common or Proper name GADOVERSETAMIDE INJECTION
Company Name LIEBEL-FLARSHEIM CANADA INC
Active Ingredient(s) GADOVERSETAMIDE
Strength(s) 330.9MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5, 10, 15, 20mL vials
ATC code V08CA
ATC description MAGNETIC RESONANCE IMAGING CONTRAST MEDIA
Reason for discontinuation Business reasons
Anticipated discontinuation date 2017-12-31
Actual discontinuation date 2018-03-23
Remaining supply date 2018-03-23
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 7500 TRANS-CANADA HIGHWAY
POINTE-CLAIRE, QUEBEC
CANADA H9R 5H8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2018-03-28 French Compare
v8 2018-03-28 English Compare
v7 2018-03-28 French Compare
v6 2018-03-28 English Compare
v5 2018-03-28 English Compare
v4 2018-01-22 French Compare
v3 2018-01-22 English Compare
v2 2017-05-03 French Compare
v1 2017-05-03 English Compare